Bone and joint infections (BJI), although infrequent (prevalence of 70 per 100,000 in France), have a significant economic and clinical impact. Between 2008 and 2013, the prevalence of BJI increased and infections involving joint prosthesis (PJI) represent a third of BJI in France. They are most often post-operative and more expensive than native IOAs. This study aims to describe PJI and understand the failure mechanisms of PJI in order to improve their management.
Study Type
OBSERVATIONAL
Enrollment
400
patients having had a PJI managed at the CRIOAc Lyon, with or without relapse
Hospices Civils de Lyon
Lyon, France
RECRUITINGrate of PJI
proportion of PJI among all BJI
Time frame: between 2018 and 2020
Description of PJI
acute/chronic
Time frame: between 2018 and 2020
Description of type of prosthesis PJI
number of prosthesis
Time frame: between 2018 and 2020
Description of patients having had a PJI
type of patients: age
Time frame: between 2018 and 2020
Description of comorbidities of patients having had a PJI
type of comorbidities..
Time frame: between 2018 and 2020
rate of bacteria
epidemiologic description of PJI
Time frame: between 2018 and 2020
description of antibiotic used
type of antibiotic : name
Time frame: between 2018 and 2020
description of antibiotic treatment
duration of antibiotic treatment
Time frame: between 2018 and 2020
description of surgical treatment
type of surgery: 1-step exchange, 2- step exchange, DAIR
Time frame: between 2018 and 2020
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
rate of failure
proportion of patients having a failure
Time frame: between 2018 and 2020
description of the failure
type of failure : persistence or surinfection and management of failure
Time frame: between 2018 and 2020